Jenna Davidner
Stock Analyst at Barclays
(1.33)
# 3,545
Out of 4,581 analysts
22
Total ratings
37.5%
Success rate
-1.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jenna Davidner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals | Maintained: Buy | $100 | $58.52 | +70.88% | 6 | Jul 10, 2026 | |
| COLL Collegium Pharmaceutical | Maintained: Buy | $56 | $36.29 | +54.31% | 6 | Jul 1, 2026 | |
| PHAT Phathom Pharmaceuticals | Maintained: Buy | $18 | $11.64 | +54.64% | 3 | May 15, 2026 | |
| PCRX Pacira BioSciences | Maintained: Hold | $25 | $26.40 | -5.30% | 4 | May 14, 2026 | |
| XERS Xeris Biopharma Holdings | Rated: Buy | $9 | $8.38 | +7.40% | 3 | May 13, 2026 |
Tarsus Pharmaceuticals
Jul 10, 2026
Maintained: Buy
Price Target: $100
Current: $58.52
Upside: +70.88%
Collegium Pharmaceutical
Jul 1, 2026
Maintained: Buy
Price Target: $56
Current: $36.29
Upside: +54.31%
Phathom Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $18
Current: $11.64
Upside: +54.64%
Pacira BioSciences
May 14, 2026
Maintained: Hold
Price Target: $25
Current: $26.40
Upside: -5.30%
Xeris Biopharma Holdings
May 13, 2026
Rated: Buy
Price Target: $9
Current: $8.38
Upside: +7.40%